![Hendrik-Tobias Arkenau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik-Tobias Arkenau
Oprichter bij Sarah Cannon Research Institute UK Ltd.
Actieve functies van Hendrik-Tobias Arkenau
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | - |
Oprichter | 01-01-1993 | - |
Loopbaan van Hendrik-Tobias Arkenau
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Commercial Services |